The Right RIA For You. All content copyrighted © 2019 – onwards by Ambastha Financial LLC.
By Kuldip K. Ambastha On Thursday, June 2, 2022, the stock price of Chewy, Inc. (CHWY) rose by +24.2% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of March 29-April 1, 2021; By Kuldip K. Ambastha.”) Chewy, Inc. (CHWY), an online retailer of pet food and …
Continue reading “What Caught Our Attention in the Investment World? – Week of May 31-June 3, 2022”
By Kuldip K. Ambastha Snap Inc. (SNAP), a social media technology company with smartphone camera application Snapchat as its flagship offering, had its stock price drop by -43.1% per share on Tuesday, May 24, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of April 20-24, 2020; By …
Continue reading “What Caught Our Attention in the Investment World? – Week of May 23-27, 2022”
By Kuldip K. Ambastha Ross Stores, Inc. (ROST), an American chain (“Ross Dress for Less”) of discount department stores, had its stock price drop by -22.5% per share on Friday, May 20, 2022. 1Q2022 sales were down from the same figure released for 1Q2021. Inflationary pressures have resulted in customers spending less overall, including at …
Continue reading “What Caught Our Attention in the Investment World? – Week of May 16-20, 2022”
By Kuldip K. Ambastha The stock price of Unity Software Inc. (U), a videogame software development company, fell by -37.0% per share on Wednesday, May 11, 2022. In Unity Software’s latest quarterly conference call, company leaders disclosed impressive 1Q2022 results, but also noted disappointing 2Q2022 and 2022 full-year guidance. Wall Street was displeased with the …
Continue reading “What Caught Our Attention in the Investment World? – Week of May 9-13, 2022”
By Kuldip K. Ambastha On Tuesday, May 3, 2022, the stock price of Chegg, Inc. (CHGG), a direct-to-student online learning platform, dropped by -30.3% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of November 1-5, 2021; By Kuldip K. Ambastha.”) In the latest quarter, the company …
Continue reading “What Caught Our Attention in the Investment World? – Week of May 2-6, 2022”
By Kuldip K. Ambastha The stock of Teladoc Health, Inc. (TDOC), a multinational virtual healthcare and telemedicine company, dropped by -40.2% per share on Thursday, April 28, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of April 26-30, 2021; By Kuldip K. Ambastha.”) Wall Street did not …
Continue reading “What Caught Our Attention in the Investment World? – Week of April 25-29, 2022”
By Kuldip K. Ambastha On Wednesday, April 20, 2022, the stock price of Netflix, Inc. (NFLX), a subscription streaming service and production company, dropped by -35.1% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of July 15-19, 2019; By Anil K. Ambastha and Kuldip K. Ambastha.”) …
Continue reading “What Caught Our Attention in the Investment World? – Week of April 18-22, 2022”
By Kuldip K. Ambastha Peloton Interactive, Inc. (PTON), a luxury exercise gear maker, had its stock drop by -4.6% for the trading day of Thursday, April 14, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of May 3-7, 2021; By Kuldip K. Ambastha” and “What Caught Our …
Continue reading “What Caught Our Attention in the Investment World? – Week of April 11-14, 2022”
By Kuldip K. Ambastha Sprinklr, Inc. (CXM), an American Software-as-a-Service (SaaS) technology company offering a customer experience management platform (CEMP), had its stock price increase by +21.2% for the trading day of Thursday, April 7, 2022. Sprinklr impressed Wall Street with its most recent quarterly and yearly results on several fronts – earnings, sales, revenues, …
Continue reading “What Caught Our Attention in the Investment World? – Week of April 4-8, 2022”
By Kuldip K. Ambastha Longeveron Inc. (LGVN), a biotechnology company focused on clinical stage therapies, had its stock price rise by +105.4% per share on Thursday, March 31, 2022. On this trading day, a great piece of news led to a great return. Lomecel-B has shown positive results from its Phase 1 trial testing on …